GIM
TEVA icon

Goelzer Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Goelzer Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-74,976
Closed -$2.72M – 202
2016
Q4 		$2.72M Buy
74,976
+7,636
+11% +$305K 0.35% 106
2016
Q3 		$3.1M Buy
67,340
+4,685
+7% +$244K 0.42% 101
2016
Q2 		$3.15M Buy
62,655
+1,362
+2% +$72.5K 0.43% 96
2016
Q1 		$3.28M Buy
61,293
+1,214
+2% +$71.2K 0.47% 93
2015
Q4 		$3.94M Buy
60,079
+3,680
+7% +$227K 0.58% 64
2015
Q3 		$3.18M Buy
56,399
+908
+2% +$58.9K 0.51% 85
2015
Q2 		$3.28M Buy
55,491
+59
+0.1% +$3.64K 0.5% 88
2015
Q1 		$3.45M Buy
55,432
+115
+0.2% +$6.69K 0.52% 85
2014
Q4 		$3.18M Buy
55,317
+4,731
+9% +$264K 0.48% 98
2014
Q3 		$2.72M Sell
50,586
-370
-0.7% -$19.6K 0.45% 103
2014
Q2 		$2.67M Buy
50,956
+835
+2% +$42.7K 0.44% 108
2014
Q1 		$2.65M Sell
50,121
-779
-2% -$36K 0.47% 96
2013
Q4 		$2.04M Sell
50,900
-2,323
-4% -$91.5K 0.37% 116
2013
Q3 		$2.01M Sell
53,223
-53,663
-50% -$2.09M 0.41% 107
2013
Q2 		$4.19M Buy
+106,886
New +$4.16M 0.45% 103

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goelzer Investment Management's TEVA Position: Q1 2017 in Review

Goelzer Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 74,976 shares — an estimated $2.72M sold.

Goelzer Investment Management first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $4.19M in Q2 2013. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Goelzer Investment Management reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Goelzer Investment Management sold 74,976 Teva Pharmaceuticals shares in Q1 2017, an estimated $2.72M.
  • Goelzer Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Goelzer Investment Management's Teva Pharmaceuticals position peaked at $4.19M in Q2 2013.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Goelzer Investment Management's 13F filing for Q1 2017, filed 5 May 2017.